DOI: https://dx.doi.org/10.18565/urology.2020.1.85-92
А.Г. Мартов, С.В. Попов, В.М. Обидняк, Н.К. Гаджиев, Р.Г. Гусейнов, Д.С. Горелов, Г.Н. Акопян, З.К. Гаджиева, Н.Ю. Спиридонов, С.Б. Петров
1 Кафедра урологии и андрологии ИППО ФМБЦ им. А. И. Бурназяна ФМБА России, Москва, Россия; 2 отдел урологии и андрологии медицинского исследовательского центра МГУ им. М. В. Ломоносова, Москва, Россия; 3 отделение урологии ГБУЗ «ГКБ им. Д. Д. Плетнёва» ДЗМ, Москва, Россия; 4 СПбГБУЗ «Клиническая больница святителя Луки», Санкт-Петербург, Россия; 5 отделение урологии № 2 (дистанционной литотрипсии и эндовидеохирургии) НИИ ХиНМ ФГБОУ «Первый Санкт-Петербургский государственный медицинский Университет им. И. П. Павлова», Санкт-Петербург, Россия; 6 ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский университет), Москва, Россия; 7 Многопрофильный медицинский центр «MedClub», Санкт-Петербург
1. Bloom D.A., Clayman R.V., McDougal E. Stents and related terms: a brief history. Urology. 1999;54(4):767–771. 2. Finney R.P. Experience with new double J ureteral catheter stent. J. Urol. 1978;120(6):678–681. 3. Hofmann R., Hartung R. Ureteral stents – materials and new forms. World J. Urol. 1989;7(3):154–157. 4. Traxer O. et al. Effects of silicone hydrocoated double loop ureteral stent (DJ) on symptoms and quality of life in patients undergoing F-URS for kidney stone: Final results of a prospective randomized multicentre clinical study. Eur. Urol. Suppl. 2019;18(1):е198–e199. 5. Gadzhiev N. et al. Comparison of silicone versus polyurethane ureteral stents: A prospective controlled study. BMC Urol. 2020; 20(1):10. 6. Tunney M.M., Keane P.F., Gorman S.P. Assessment of urinary tract biomaterial encrustation using a modified Robbins device continuous flow model. J. Biomed. Mater. Res. 1997;38(2):87–93. 7. Gorman S.P., Jones D.S., Bonner M.C., Akay M., Keane P.F. Mechanical performance of polyurethane ureteral stents in vitro and ex vivo. Biomaterials. 1997;18(20):1379–1383. 8. Venkatesan N., Shroff S., Jayachandran K., Doble M. Polymers as Ureteral Stents. J. Endourol. 2010;24(2):191–198. 9. Pollak J.S., Rosenblatt M.M., Egglin T.K., Dickey K.W., Glickman M. Treatment of ureteral obstructions with the Wallstent endoprosthesis: preliminary results. J. Vasc. Interv. Radiol. 1995;6(3):417–425. 10. Liatsikos E. et al. Ureteral Obstruction: Is the Full Metallic Double-Pigtail Stent the Way to Go? Eur. Urol. 2010;57(3):480–487. 11. Klarskov P., Nordling J., Nielsen J.B. Experience with Memokath 051 ureteral stent. Scand. J. Urol. Nephrol. 2005;39(2):169–172. 12. Pétas A., Vuopio-Varkila J., Siitonen A., Välimaa T., Talja M., Taari K. Bacterial adherence to self-reinforced polyglycolic acid and self-reinforced polylactic acid 96 urological spiral stents in vitro. Biomaterials. 1998;19(7–9):677–681. 13. Lingeman J.E. et al. Use of a Temporary Ureteral Drainage Stent After Uncomplicated Ureteroscopy: Results From a Phase II Clinical Trial. J. Urol. 2003;169(5):1682–1688. 14. Amiel G.E., Yoo J.J., Kim B.S., Atala A. Tissue engineered stents created from chondrocytes. J. Urol. 2001;165(6 Pt 1):2091–2095. 15. Joshi H.B., Stainthorpe A., Macdonagh R.P., Keeley F.X., Timoney A.G., Barry M.J. Indwelling Ureteral Stents: Evaluation of Symptoms, Quality of Life and Utility. J. Urol. 2003;169(3):1065–1069. 15. El-Nahas A.R., El-Assmy A.M., Shoma A.M., Eraky I., El-Kenawy M.R., El-Kappany H.A. Self-Retaining Ureteral Stents: Analysis of Factors Responsible For Patients’ Discomfort. J. Endourol. 2006;20(1):33–37. 16. Kitaya K., Tada Y., Hayashi T., Taguchi S., Funabiki M., Nakamura Y. Comprehensive endometrial immunoglobulin subclass analysis in infertile women suffering from repeated implantation failure with or without chronic endometritis. Am. J. Reprod. Immunol. 2014;72(4):386–391. 17. Martov A.G., Ergakov D.V., Kornienko S.I. et al. An improvement of the quality of life of patients with internal stents by means of changing their shape. Urologiia. 2011;2:7–13. Russian (Мартов А.Г., Ергаков Д.В., Корниенко С.И. и соавт. Улучшение качества жизни пациентов с внутренними стентами путём изменения их формы. Урология. 2011;2:7–13). 18. Macaluso J.N., Deutsch J.S., Goodman J.R., Appell R.A., Prats L.J., Wahl P. The use of the Magnetip double-J ureteral stent in urological practice. J. Urol. 1989;142(3):701–703. 19. John T., Rajpurkar A., Smith G., Fairfax M., Triest J. Antibiotic Pretreatment of Hydrogel Ureteral Stent. J. Endourol. 2007;21(10):1211–1216. 20. Khandwekar A.P., Doble M. Physicochemical characterisation and biological evaluation of polyvinylpyrrolidone-iodine engineered polyurethane (Tecoflex®). J. Mater. Sci. Mater. Med. 2011;22(5):1231–1246. 21. Stickler D.J., Evans A., Morris N., Hughes G. Strategies for the control of catheter encrustation. Int. J. Antimicrob. Agents. 2002;19(6):499–506. 22. Jones D.S., Garvin C.P., Dowling D., Donnelly K., Gorman S.P. Examination of surface properties andin vitro biological performance of amorphous diamond-like carbon-coated polyurethane. J. Biomed. Mater. Res. Part B Appl. Biomater. 2006;78B(2):230–236. 23. Laube N., Kleinen L., Bradenahl J., Meissner A. Diamond-Like Carbon Coatings on Ureteral Stents – A New Strategy for Decreasing the Formation of Crystalline Bacterial Biofilms? J. Urol. 2007;177(5):1923–1927. 24. Watterson J.D. et al. Oxalate-Degrading Enzymes from Oxalobacter formigenes: A Novel Device Coating to Reduce Urinary Tract Biomaterial-Related Encrustation. J. Endourol. 2003;17(5):269–274. 25. Zupkas P., Parsons C.L., Percival C., Monga M. Pentosanpolysulfate Coating of Silicone Reduces Encrustation. J. Endourol. 2000;14(6):483–488. 26. Multanen M. et al. Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra. Urol. Res. 2002;30(4):227–232. 27. Ko R., Cadieux P.A., Dalsin J.L., Lee B.P., Elwood C.N., Razvi H. First Prize: Novel Uropathogen-Resistant Coatings Inspired by Marine Mussels. J. Endourol. 2008;22(6):1153–1160. 28. Mendez-Probst C.E. et al. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial. BJU Int. 2012;110(5):749–754. 29. Krambeck A.E. et al. A Novel Drug Eluting Ureteral Stent: A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of a Ketorolac Loaded Ureteral Stent. J. Urol. 2010;183(3):1037–1043. 30. Phuengkham H., Nasongkla N. Development of antibacterial coating on silicone surface via chlorhexidine-loaded nanospheres. J. Mater. Sci. Mater. Med. 2015;26(2):78. 31. Liatsikos E.N. et al. Application of Paclitaxel-Eluting Metal Mesh Stents within the Pig Ureter: An Experimental Study. Eur. Urol. 2007;51(1):217–223. 32. Kallidonis P. et al. Evaluation of Zotarolimus-Eluting Metal Stent in Animal Ureters. J. Endourol. 2011;25(10):1661–1667. 33. Wilson M., Devine D., Eds. Medical Implications of Biofilms. Cambridge: Cambridge University Press, 2003. 34. Komyakov B., Guliyev B. Internal drainage of the upper urinary tract in ureteral tumor obstructions: a review of literature. Cancer Urol. 2010;6(2). 35. Kehinde E.O. et al. Factors predisposing to urinary tract infection after J ureteral stent insertion. J. Urol. 2002;167(3):1334–1337. 36. Bouzidi H. et al. Caractéristiques des incrustations des endoprothèses urétérales chez les patients lithiasiques. Progrès en Urol. 2008;18(4):230–237. 37. Wolf J.S. et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J. Urol. 2008;179(4):1379–1390. 38. Paick S.H., Park H.K., Oh S.-J., Kim H.H. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology. 2003;62(2):214–217. 39. Breau R.H., Norman R.W. Optimal prevention and management of proximal ureteral stent migration and remigration. J. Urol. 2001;166(3):890–893. 40. Martov A.G., Ergakov D.V., Novikov A.B. Modern possibilities for improving the quality of life of patients with internal stents. Urology. 2018;2:134–142. Russian (Мартов А.Г., Ергаков Д.В., Новиков А.Б. Современные возможности улучшения качества жизни пациентов с внутренними стентами. Урология. 2018;2:134–142). 41. Sivalingam S., Streeper N.M., Sehgal P.D., Sninsky B.C., Best S.L.,Nakada S.Y. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial. J. Urol. 2016;195(2):385–390. 42. Beiko D.T. et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J. Endourol. 2004;18(8):723–730. 43. Komiakov B.K., Guliev B.G. Rehabilitation of patients with ‘forgotten’ stents. Urologiia. 2014;5:107–110. 44. Gadzhiev N.K.et al. Metaphylaxis of urolithiasis: new look, modern approach, implementation in a mobile application. Urologiia. 2017;1:124–129. 45. Ather M.H., Talati J., Biyabani R. Physician responsibility for removal of implants: the case for a computerized program for tracking overdue double-J stents. Tech. Urol. 2000;6(3):189–192. 46. Barnes K.T., Bing M.T., Tracy C.R. Do ureteric stent extraction strings affect stent-related quality of life or complications after ureteroscopy for urolithiasis: a prospective randomised control trial. BJU Int. 2014;113(4):605–609. 47. Gadzhiev N. et al. Ultrasound-Guided Ureteral Stent Removal in Women. J. Ultrasound Med. 2016;35(10):2159–2163.
А в т о р д л я с в я з и: В. М. Обидняк – врач-уролог, отделение урологии № 2 (дистанционной литотрипсии
и эндовидеохирургии) НИИ ХиНМ ФГБОУ «Первый Санкт-Петербургский государственный медицинский университет
им. И. П. Павлова», Санкт-Петербург, Россия; e-mail: v.obidniak@gmail.com